Calliditas Therapeutics AB Sponsored ADR Net Income 2020-2024 | CALT
Calliditas Therapeutics AB Sponsored ADR net income from 2020 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Calliditas Therapeutics AB Sponsored ADR Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $-44 |
| 2022 | $-41 |
| 2021 | $-58 |
| 2020 | $-47 |
| 2019 | $-3 |
| Calliditas Therapeutics AB Sponsored ADR Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-4 |
| 2024-03-31 | $-24 |
| 2023-12-31 | $-2 |
| 2023-09-30 | $-16 |
| 2023-06-30 | $-9 |
| 2023-03-31 | $-18 |
| 2022-12-31 | $2 |
| 2022-09-30 | $-1 |
| 2022-06-30 | $-20 |
| 2022-03-31 | $-22 |
| 2021-12-31 | $-26 |
| 2021-09-30 | $1 |
| 2021-06-30 | $-19 |
| 2021-03-31 | $-15 |
| 2020-12-31 | $-19 |
| 2020-09-30 | $-16 |
| 2020-06-30 | $-6 |
| 2020-03-31 | $-7 |
| 2019-12-31 | $-2 |
| 2019-09-30 | $-5 |
| 2019-06-30 | $9 |
| 2019-03-31 | $-5 |
